跳至主要内容
临床试验/NCT01755247
NCT01755247已完成1 期

A Phase One, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN10000 Topical Gel in Healthy Volunteers

Novan, Inc.1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Novan, Inc.
入组人数
15
试验地点
1
主要终点
Cutaneous tolerability

研究概览

简要总结

A Phase I, Single-Center, Open-Label, Randomized, Parallel Group, 3 Day Study Evaluating the Safety and Cutaneous Tolerability of NVN1000 Topical Gel in Healthy Volunteers

详细描述

This is a 3 day study to assess safety and tolerability of a new topical gel product, NVN1000 with and without the application of a commercially available moisturizer in approximately 15 healthy subjects. The test product will be applied to the forehead of healthy volunteers once daily for 3 days. One group of subjects will have a moisturizer applied to the same area 15 minutes after the test gel was applied and one group of subjects will be treated with the gel vehicle which does not contain the active product. The hypothesis is that the application of moisturizer will not effect safety or local tolerability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Male and Females > 18 years of age
  • High degree of fluorescence of facial skin under Wood's lamp

排除标准

  • Acute or chronic skin disorders
  • Topical or systemic antibiotics within 4 weeks of study enrollment
  • Use of medication that increases risk of methemoglobinemia or influences P. acnes counts
  • Subjects with medical illnesses, anemia, elevated methemoglobin
  • Women who are pregnant, nursing or planning a pregnancy

研究组 & 干预措施

Topical Gel Vehicle

Placebo Comparator

Once daily application of topical gel vehicle to forehead for 3 days

干预措施: Topical Gel Vehicle (Drug)

8% NVN1000 Topical Gel

Active Comparator

Once daily application of 8% NVN1000 Topical Gel to the forehead for 3 days

干预措施: 8% NVN1000 Topical Gel (Drug)

8% NVN1000 Topical Gel and moisturizer

Active Comparator

Once daily application of 8% NVN1000 Topical Gel to the forehead, followed 15 minutes later by application of a commercially available moisturizer

干预措施: 8% NVN1000 Topical Gel and moisturizer (Drug)

结局指标

主要结局

Cutaneous tolerability

时间窗: 3 days

Tolerability based on a four point scale (0-3) for erythema, scaling ,dryness, pruritus, and burning/stinging.

次要结局

  • Safety comparison(3 Days)

研究者

发起方
Novan, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验